Evaluation of EGFR Mutation Testing Concordance Between Next-Generation Sequencing and Biocartis Idylla Console in NSCLC
{{output}}
Objective: The aim of this study was to evaluate the concordance of in-house epidermal growth factor receptor (EGFR) mutation testing using the Biocartis Idylla (Idylla) platform compared with next-generation sequencing (NGS) for... ...
